Leerink Partners Downgrades Aurinia Pharmaceuticals (AUPH) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: AUPH) | Delayed: 17.14 +0.58 (3.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.56 | 52 Week High | $5.69 | |||
| Open | $16.88 | 52 Week Low | $1.42 | |||
| Day High | $17.40 | P/E | N/A | |||
| Day Low | $16.56 | EPS | $0.00 | |||
| Volume | 1,101,374 | |||||
